The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial.
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Guardant Health; Hengrui Therapeutics; Mersana; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Daiichi Sankyo (Inst); GRAIL (Inst); Guardant Health (Inst); Hengrui Therapeutics (Inst); Illumina (Inst); Roche/Genentech (Inst)
 
Ronglai Shen
Research Funding - GRAIL
 
Michael Offin
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Darren J. Buonocore
Stock and Other Ownership Interests - Merck; Novartis
 
Mackenzie L. Myers
No Relationships to Disclose
 
Aishwarya Venkatesh
No Relationships to Disclose
 
Pedram Razavi
Consulting or Advisory Role - Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
 
Michelle S. Ginsberg
No Relationships to Disclose
 
Gary A. Ulaner
Speakers' Bureau - Sanofi
Patents, Royalties, Other Intellectual Property - GE Healthcare; Genentech; Novartis; Sanofi
 
David B. Solit
Stock and Other Ownership Interests - Loxo
Consulting or Advisory Role - Illumina; Intezyne Technologies; Loxo; Pfizer; Vividion Therapeutics
Travel, Accommodations, Expenses - Merck KGaA
 
David Michael Hyman
Consulting or Advisory Role - AstraZeneca; Atara Biotherapeutics; Bayer; Boehringer Ingelheim; Chugai Pharma; CytomX Therapeutics; Genentech; Pfizer
Research Funding - AstraZeneca; Loxo; Puma Biotechnology
Travel, Accommodations, Expenses - Chugai Pharma; Genentech
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo; Elucida Oncology; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar; Seagen
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
Erika Gedvilaite
No Relationships to Disclose
 
Dana Tsui
Other Relationship - Nanodigmbio and Cambridge Healthtech Institute
 
Maria E. Arcila
Honoraria - Invivoscribe
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Memorial Sloan-Kettering Cancer Center
 
Gregory Weitsman
No Relationships to Disclose
 
Tony Ng
No Relationships to Disclose
 
Maurizio Scaltriti
Research Funding - Daiichi Sankyo (Inst); Puma Biotechnology (Inst)
 
Alan Loh Ho
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; Eisai; Genzyme; Merck; Novartis; Regeneron; Sanofi; Sun Pharma; TRM Oncology
Speakers' Bureau - Medscape; Novartis; Omniprex America
Research Funding - Allos Therapeutics; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; Ayala Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly; Merck; Novartis; Novartis; Pfizer
Travel, Accommodations, Expenses - Ayala Pharmaceuticals; Ignyta; Janssen Oncology; Kura Oncology; Kura Oncology; Kura Oncology; Merck